Skip to main content
FSCDR 2025 Annual Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Livestream
Livestream
On Demand
On Demand
Meal
Meal
Ticketed Event
Ticketed Event

Adam Wufsus, PhD

Director, Rare Disease Medical
Novo Nordisk Inc
Golden, Colorado, United States

Adam Wufsus, Medical Director, Rare Blood Disorders, NNI, holds a PhD in chemical engineering and has over a decade of experience in rare hematological disorders across numerous settings. His work spans from basic research, where he has published numerous works on the interplay between biochemical and biophysical properties on thrombosis and hemostasis, to medical affairs, where he has been part of several product launches including Rebinyn and Esperoct. Starting in 2020, Adam began serving and interim medical director and then medical director with a focus on sickle cell disease. In this setting Adam aims to work collaboratively with HCPs, patients, and other stakeholders to drive patient-centricity within Novo Nordisk’s sickle cell development program.

Presentation(s):